These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29073298)

  • 21. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.
    Glintborg D; Hass Rubin K; Nybo M; Abrahamsen B; Andersen M
    Eur J Endocrinol; 2015 May; 172(5):627-38. PubMed ID: 25656495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y
    Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
    Legro RS; Kunselman AR; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
    Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovary syndrome in adolescence.
    Buggs C; Rosenfield RL
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):677-705, x. PubMed ID: 16085166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'.
    Bhattacharya SM; Jha A
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1303-7. PubMed ID: 21535308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.
    Kenigsberg LE; Agarwal C; Sin S; Shifteh K; Isasi CR; Crespi R; Ivanova J; Coupey SM; Heptulla RA; Arens R
    Fertil Steril; 2015 Nov; 104(5):1302-9.e1-4. PubMed ID: 26354095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
    Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
    Shigiyama F; Kumashiro N; Rikitake T; Usui S; Saegusa M; Kitamura M; Uchino H; Hirose T
    Endocr J; 2016; 63(2):193-8. PubMed ID: 26765270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008.
    Okoroh EM; Hooper WC; Atrash HK; Yusuf HR; Boulet SL
    Am J Obstet Gynecol; 2012 Oct; 207(4):299.e1-7. PubMed ID: 22921097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.
    Amato MC; Guarnotta V; Ciresi A; Modica R; Pantò F; Giordano C
    J Clin Endocrinol Metab; 2014 Jan; 99(1):203-11. PubMed ID: 24243639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty.
    Franceschi R; Gaudino R; Marcolongo A; Gallo MC; Rossi L; Antoniazzi F; Tatò L
    Fertil Steril; 2010 Mar; 93(4):1185-91. PubMed ID: 19135667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome and intervening factors in adolescents from 15 to 18 years old.
    Faria FR; Gusmão LS; Faria ER; Gonçalves VS; Cecon RS; Franceschini Sdo C; Priore SE
    Rev Assoc Med Bras (1992); 2013; 59(4):341-6. PubMed ID: 23850029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.